Publication:
Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae.

dc.contributor.authorAyerbe-Algaba, Rafael
dc.contributor.authorGil-Marqués, María Luisa
dc.contributor.authorJiménez-Mejías, Manuel Enrique
dc.contributor.authorSánchez-Encinales, Viviana
dc.contributor.authorParra-Millán, Raquel
dc.contributor.authorPachón-Ibáñez, María Eugenia
dc.contributor.authorPachón, Jerónimo
dc.contributor.authorSmani, Younes
dc.date.accessioned2023-01-25T10:23:33Z
dc.date.available2023-01-25T10:23:33Z
dc.date.issued2018-10-03
dc.description.abstractColistin is among the few antibiotics effective against multidrug-resistant Acinetobacter baumannii and Klebsiella pneumoniae clinical isolates. However, in the last few years, colistin-resistant A. baumannii and K. pneumoniae strains have emerged. Therefore, combination therapies, between colistin and other old drugs, restoring the activity of colistin are required. The main objective of this study was to analyse the activity of niclosamide, an anthelmintic drug, in combination with colistin against colistin-susceptible (Col-S) and colistin-resistant (Col-R) A. baumannii and K. pneumoniae. The MIC were determined by microdilution assay and the time-kill curves were performed. The zeta potential of Col-S and Col-R of A. baumannii and K. pneumoniae in presence of niclosamide was assessed. Niclosamide in combination with colistin showed improved activity against Col-S and Col-R A. baumannii and K. pneumoniae. Time-killing curves showed synergic activity between niclosamide and colistin against Col-S and Col-R A. baumannii and K. pneumoniae, especially when niclosamide or colistin was added for second time at 4 h of the 24 h killing curve. Col-R A. baumannii and K. pneumoniae in presence of niclosamide exhibited a greater negative charge (-34.95 ± 0.35 mV and -38.85 ± 0.92 mV; P
dc.identifier.doi10.3389/fcimb.2018.00348
dc.identifier.essn2235-2988
dc.identifier.pmcPMC6178895
dc.identifier.pmid30338245
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178895/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fcimb.2018.00348/pdf
dc.identifier.urihttp://hdl.handle.net/10668/13106
dc.journal.titleFrontiers in cellular and infection microbiology
dc.journal.titleabbreviationFront Cell Infect Microbiol
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number348
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAcinetobacter baumannii
dc.subjectKlebsiella pneumoniae
dc.subjectcolistin
dc.subjectniclosamide
dc.subjectrepurposing drug
dc.subjectsynergistic effect
dc.subject.meshAcinetobacter baumannii
dc.subject.meshAnti-Bacterial Agents
dc.subject.meshColistin
dc.subject.meshDrug Synergism
dc.subject.meshKlebsiella pneumoniae
dc.subject.meshMicrobial Sensitivity Tests
dc.subject.meshMicrobial Viability
dc.subject.meshNiclosamide
dc.titleSynergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number8
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC6178895.pdf
Size:
1.36 MB
Format:
Adobe Portable Document Format